close
MENU
Tech & Innovation
6 mins to read

Market muted on LanzaTech’s move into human food

The Kiwi-founded and Nasdaq-listed synbio company has launched a new protein produced from CO2 gases.

LanzaTech hopes to have a pre-commercial plant operational in 2026.

The market has had a fairly muted reaction to Kiwi-founded and Nasdaq-listed synbio company LanzaTech extending its carbon waste recycling operations to the human food market with a new protein.

The alternative protein market is valued at US$1 trillion and growing. It’s a lucrative market for the

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Fri, 11 Oct 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Market muted on LanzaTech’s move into human food
Tech & Innovation,
106255
true